Halstead Scott B
Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Korea.
Paediatr Int Child Health. 2012 May;32 Suppl 1(s1):5-9. doi: 10.1179/2046904712Z.00000000045.
Research into the pathogenesis of dengue fever has exploded over the last half-century, with issues that were considered simple becoming more complex as additional data are found. This has led to the development of a number of controversies that are being studied across the globe and debated in the literature. In this paper, the following six controversies are analysed and, where possible, resolved: the 1997 World Health Organization (WHO) case definition of dengue haemorrhagic fever (DHF) is not useful; DHF is not significantly associated with secondary dengue infection; DHF results from infection with a 'virulent' dengue virus; DHF is owing to abnormal T-cell responses; DHF results from auto-immune responses; and DHF results from direct infection of endothelial cells.
在过去的半个世纪里,对登革热发病机制的研究呈爆发式增长,随着更多数据的发现,一些原本被认为简单的问题变得更加复杂。这引发了一系列在全球范围内进行研究并在文献中展开辩论的争议。本文对以下六个争议进行了分析,并在可能的情况下加以解决:1997年世界卫生组织(WHO)登革出血热(DHF)的病例定义并无用处;DHF与二次登革感染无显著关联;DHF是由“毒性”登革病毒感染所致;DHF归因于异常的T细胞反应;DHF是自身免疫反应的结果;以及DHF是内皮细胞直接感染的结果。